How science connects in a new era of digital communication and AI
Interview with Sarah Clark-Pfister, Head of Medical Excellence and Strategic Scientific Communications, Rare Disease at Novo Nordisk
Bringing the patient’s voice to the fore in pharma communication
Interview with Jean Philippe Plançon, Chairman of the Board and President, European Patients Organization for Dysimmune & Inflammatory Neuropathies (EPODIN)
Beyond touchpoints: Rethinking oncology engagement
Interview with Itziar Canamasas, Global Head of Oncology, Boehringer Ingelheim
Cutting through the noise: Engaging HCPs in the age of AI
Interview with Natasha Hansjee, Integrated Medical Engagement Catalyst at Roche in Switzerland
Putting the customer at the centre of attention with Digital Twin
Interview with Graham Addison, Senior Director for Global Launch and Marketing Excellence, at AstraZeneca’s Global Hub in Barcelona.
Creative thinking and AI are supporting foundational products and shaping future pharma
Interview with Lorena Cabré, Global Omnichannel & Content Strategy Lead / AI powered GTM Models Expert at Roche.
Adopting a unifying mindset for digital transformation and customer engagement
Interview with Iria Gala VP, Digital & Customer Engagement, Novo Nordisk
Maximizing digital and AI for a new generation of customers
Interview with Ainara Luque Saavedra, Global (ex-U.S.) Scientific Communications Lead for Inflammation, Amgen.
Co-creation is not a buzzword. How Pharma teams can make it work (with a little help from AI)
How do you future-proof your engagement strategy without falling back on the same old tactics? One insight stood out: co-creation is no longer optional.
From DeepBlue to AI heights in healthcare
How artificial intelligence is transforming pharmaceutical development, manufacturing, and patient care